Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Exelixis Inc (NASDAQ:EXEL)

6.34
Delayed Data
As of 3:59pm ET
 +0.04 / +0.63%
Today’s Change
3.10
Today|||52-Week Range
6.81
+12.41%
Year-to-Date

Today’s Trading

Previous close6.30
Today’s open6.34
Day’s range6.21 - 6.35
Volume2,953,867
Average volume (3 months)4,830,508
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)-10.86%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+48.03%
P/E ratioNM
Price/Sales31.75
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LXRXLexicon Pharmaceutic...+0.22+1.63%
ARIAARIAD Pharmaceutical...+0.18+2.24%
ABCOAdvisory Board Co-0.08-0.25%
DBVTDBV Technologies SA+0.29+0.90%
Data as of 3:59pm ET, 05/27/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$37.2M
Annual profit (last year)-$169.7M
Net profit margin-456.63%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer &
Executive Vice President
Christopher J. Senner
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs